Serena Travaglini

10PUBLICATIONS
24CO-AUTHORS
Liquid biopsiesHaematological tumoursMolecular targetsMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 27, 2026
FLT3-ITD Measurable Residual Disease in Acute Myeloid Leukemia: Implications for FLT3 Inhibitor-Based Therapies.

|Sep 26, 2025
Metabolic Signature of FLT3-Mutated AML: Clinical and Therapeutic Implications.

Cristina Banella, Gianfranco Catalano, Maura Calvani

|Sep 10, 2025
PML::RARα+ myeloid cells display metabolic alterations that can be targeted to treat resistant/relapse acute promyelocytic leukemias.

Alessandra Zaza, Giuseppe Zardo, Cristina Banella

|Nov 27, 2024
Combination Treatment of Resistant Acute Promyelocytic Leukemia Cells with Arsenic Trioxide and Anti-Apoptotic Gene Inhibitors.

Manuela Giansanti, Tiziana Ottone, Serena Travaglini

|Oct 06, 2023
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways.

T Ottone, G Silvestrini, R Piazza

|Aug 12, 2023
YY1 Knockdown Relieves the Differentiation Block and Restores Apoptosis in AML Cells.

Nelida Ines Noguera, Serena Travaglini, Stefania Scalea

Pageof 2

Frequent Collaborators

9 joint publications

Maria Teresa Voso

4 joint publications

Nelida Ines Noguera

3 joint publications

Tiziana Ottone

3 joint publications

Carmelo Gurnari